期刊文献+

Impact of Hepatits B Vaccination as an Important Indicator for Immunization Program in Albania

Impact of Hepatits B Vaccination as an Important Indicator for Immunization Program in Albania
下载PDF
导出
摘要 Albania has been a country with a high prevalence of hepatitis B virus. Hepatitis B vaccine has been introduced nationwide in Albanian Immunization Program in 1994. Hepatitis B is given at birth, as a separate antigen, followed by three doses at 2, 4 and 6 months, where Hepatitis B, starting from 2009, is part of pentavalent vaccine of DTP-HepB-Hib. The aim of this study was to evaluate Immunization Program with Hepatitis B vaccination in order to prove program efficacy, increase public confidence in immunizations and advocate for sustainable immunization programs. Methodology was based on three components such as Immunization coverage surveys, serologic surveys and surveillance for acute cases of Hepatitis B. Results of this study showed that vaccination coverage is really high, more than 95% all over the country and with drop-out rates less than 10%. Anti-HBs levels in immunized children were very high in comparison with unimmunized ones. Incidence of HBV in children 0-14 years old is almost zero. Such results tell us that Hepatitis B vaccination is one of the most fruitful strategies for long term control of Hepatitis B disease.
出处 《Journal of Life Sciences》 2014年第2期115-119,共5页 生命科学(英文版)
关键词 Hepatitis B immunization vaccination coverage ANTI-HBS HBV incidence. 阿尔巴尼亚 疫苗接种 乙型肝炎 免疫规划 乙肝病毒 免疫程序 血清学调查 乙肝疫苗
  • 相关文献

参考文献15

  • 1WHO/IVB, The immunological basis for immunization series: Module 22: Hepatitis B, Dec. 2012, pp. 2-5. 被引量:1
  • 2Recommendations of the European Technical Advisory Group of Experts on Immunization (ETAGE), World Health Organization, Regional Office for Europe, 2004, http ://www.vhpb.org/files/html/Meetings_and_publicatio ns/VHPB_Meetings/Kyiv2004/backgrounddoc/A2EETA GErecommendationseng.pdf. 被引量:1
  • 3Reunion de Consensus, Vaccination contre le virus de I'hepatite B--Texte des Recommendations, Paris, September 10-11, 2003, http://www.infectiologie.com/ public/documents/o fficiels/vaccins/cc%20vaccin%20hvb 03.pdf. 被引量:1
  • 4A. Levitt, A. Vorsters, N. Emiroglu, S. Goldstein, T. Godal, M. Kane, et al., Strengthening Immunization Systems and Introduction of Hepatitis B Vaccine in Central and Eastern Europe and the Newly Independent States, Kiev, Ukraine, 2004, pp. 29-31. 被引量:1
  • 5Expand Program on Immunization, Vaccination Coverage For All Antigens From 2000-2012, IPH Report, 2013. 被引量:1
  • 6National Survey of Vaccination Coverage, EPI-IPH, Albania, 1999, pp. 3-8. 被引量:1
  • 7D. Fitz Simons, P. Van Damme, N. Emiroglu, T. Godal, M. Kane, A. Malyavin, et al., Prevention and control of Hepatitis B in central and eastern Europe and the newly independent states, Report of Meeting in St. Petersburg, Russian Federation, June 2001. 被引量:1
  • 8Viral Hepatitis Prevention Board, Hepatitis B vaccination, long-term immunogenicity and efficacy of hepatitis B vaccine, Viral Hepatitis Issue, Vol. 20.2, Geneva, Switzerland, Jul. 2003, pp. 2-5. 被引量:1
  • 9Immunization Works, Everything you need to know about immunization in one CD, Pink Book: Vaccination against Hepatitis B infection, Department of Health and Human Services, CDC, Atlanta, Georgia, pp. 117-119, 124-126. 被引量:1
  • 10WHO/IVB, Immunization in Practice: Monitoring Your Data, WHO, Geneva, 2004, pp. 2-7. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部